Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer: final analysis of the randomized RATIONALE-315 trial
Year: 2025
Type: article
Language: en
Topic: Cancer Immunotherapy and Biomarkers
Authors and affiliations:
raw_author_name: C. Wang
raw_affiliation_strings: Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University, Cancer Institute and Hospital, Tianjin, China
raw_author_name: W. Wang
raw_affiliation_strings: The Second Department of Thoracic Surgery, Hunan Cancer Hospital, Hunan, China
raw_author_name: H. Liu
raw_affiliation_strings: Department of Thoracic Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, Shenyang, China
raw_author_name: Q. Chen
raw_affiliation_strings: Department of Thoracic Oncological Surgery, Zhejiang Cancer Hospital, Hangzhou, China
raw_author_name: C. Chen
raw_affiliation_strings: Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China
raw_author_name: L. Liu
raw_affiliation_strings: Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China
raw_author_name: P. Zhang
raw_affiliation_strings: Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
raw_author_name: G. Zhao
raw_affiliation_strings: Department of Thoracic Surgery, Ningbo Second Hospital, Ningbo, China
raw_author_name: F. Yang
raw_affiliation_strings: Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China
raw_author_name: G. Han
raw_affiliation_strings: Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan, China
raw_author_name: B. Yu
raw_affiliation_strings: Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, China
raw_author_name: Y. Yang
raw_affiliation_strings: The Second Department of Thoracic Surgery, Beijing Cancer Hospital, Beijing, China
raw_author_name: H. Chen
raw_affiliation_strings: Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
raw_author_name: J. Jiang
raw_affiliation_strings: Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China
raw_author_name: L. Tan
raw_affiliation_strings: Department of Thoracic Surgery, Affiliated Zhongshan Hospital of Fudan University, Shanghai, China
raw_author_name: S. Xu
raw_affiliation_strings: Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, China
raw_author_name: N. Mao
raw_affiliation_strings: Department of Thoracic Surgery, The Tumor Hospital Affiliated to Guangxi Medical University, Nanning, China
raw_author_name: J. Hu
raw_affiliation_strings: Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
raw_author_name: L. Zhang
raw_affiliation_strings: Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
raw_author_name: Z. Zhang
raw_affiliation_strings: Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University, Cancer Institute and Hospital, Tianjin, China
raw_author_name: B. Yao
raw_affiliation_strings: BeOne Medicines, Ltd., Beijing, China
raw_author_name: S. Wang
raw_affiliation_strings: BeOne Medicines, Ltd., Shanghai, China
raw_author_name: S. Leaw
raw_affiliation_strings: BeOne Medicines, Ltd., Shanghai, China
raw_author_name: K. Naicker
raw_affiliation_strings: BeOne Medicines, Ltd., London, UK
raw_author_name: W. Zheng
raw_affiliation_strings: BeOne Medicines, Ltd., Beijing, China
raw_author_name: C. Yu
raw_affiliation_strings: BeOne Medicines, Ltd., Shanghai, China
raw_author_name: D. Yue
raw_affiliation_strings: Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. Electronic address: yuedongsheng_cg@163.com
Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University, Cancer Institute and Hospital, Tianjin, China. Electronic address: yuedongsheng_cg@163.com